Basic/Clinical Science Session
Mechanistic Insights on Urinary Stone Formation
November 09, 2025 | 09:30 AM - 11:30 AM
Location: Room 370A, Convention Center
Session Description
Both genetic and environmental factors contribute to stone risk. Ongoing research that examines a range of these factors, including common and rare genetic variation, frequently used medications, and urothelial bacteria, has the potential to improve understanding of kidney stone pathophysiology and therapeutic approaches.
Learning Objective(s)
- Explain how genetic variation contributes to the risk of kidney stone formation
- Identify key enzymes that could be targeted to affect oxalate metabolism
- Describe the impact of SGLT2 inhibitors on urinary calcium and uric acid levels
- Explain how urothelial bacterial populations can affect stone formation and be influenced by antibiotics
Learning Pathway(s)
- Bones‚ Stones‚ and Mineral Metabolism
Moderators
Presentations
- Using Genome-Wide Association Studies to Define Genetic Risks for Mineral Metabolism and Nephrolithiasis
09:30 AM - 10:00 AM
- Targeting Proline Dehydrogenase 2 to Reduce Oxalate Secretion
10:00 AM - 10:30 AM
- SGLT2 Inhibitors and Calcium and Uric Acid Stones
10:30 AM - 11:00 AM
- Antibiotics, Uropathogens, and Calcium Stone Formation
11:00 AM - 11:30 AM